To access this element change to forms mode OFF
Grant Award View - GA302954
Advancing congenital and childhood-onset muscle disease diagnosis and...
GA ID:
GA302954
Agency:
Department of Health and Aged Care
Approval Date:
7-Apr-2022
Publish Date:
17-May-2023
Category:
Medical Research
Grant Term:
7-Apr-2022 to 31-Mar-2026
Value (AUD):
$2,499,988.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Advancing congenital and childhood-onset muscle disease diagnosis and treatment - a cross-disciplinary Australian collaboration
Purpose:
Congenital and childhood-onset muscle disorders cause significant physical disability and early death. Limited genetic diagnosis rates and lack of effective drug treatments adversely impact patient care. We aim to (1) Increase diagnosis rates by identifying previously unrecognised disease-causing variants in new and known genes (2) Confirm the abnormal impacts of these variants within cells, tissues and animal models (3) Establish a drug development consortium to develop effective treatments.
GO ID:
GO Title:
MRFF – EPCDR Initiative – 2021 Chronic Musculoskeletal Conditions in Children and Adolescents Grant Opportunity
Internal Reference ID:
2022/MRF2016906
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Kensington
Town/City:
Kensington
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA